Table 4.
Anti-HBs IgG titres in all study groups categorized on the basis of HBV birth dose administration.
| Parameter | Pre-pentavalent vaccination | Post-pentavalent vaccination | ||||
|---|---|---|---|---|---|---|
| Birth status (No) | PT1 (33) | PT2 (80) | FT (80) | PT1 (24) | PT2 (55) | FT (54) |
| Irrespective of birth dose | ||||||
| Anti-HBs+ve | 19 (57.7%) | 59 (73.7%) | 55 (68.7%) | 24(100%) | 44 (97.8%) | 54(100%) |
| >10mIU/ml | 2(6.06%) | 6 (7.5%) | 12 (15%) | 22 (91.7%) | 40 (88.8%) | 54(100%) |
| GMT | 0.31 | 2.68 | 0.52 | 253.8 | 275.9 | 306.8 |
| Birth dose administered | ||||||
| Number | 0 | 39 | 75 | 0 | 28 | 50 |
| Anti-HBs+ve | – | 33(94.2%) | 51 (68%) | – | 27 (96.42%) | 50(100%) |
| >10 mIU/ml | – | 4 (10.25%) | 11 (14.6%) | – | 26(92.85%) | 50(100%) |
| GMT | – | 1.86 | 0.53 | – | 157.4 | 312.72 |
| No birth dose | ||||||
| Number | 33 | 41 | 5 | 24 | 27 | 4 |
| Anti-HBs+ve | 19 (57.7%) |
29 (70.73%) | 4 (80%) |
22 (91.7%) |
27 (100%) |
4 (100%) |
| >10mIU/ml | 2(6.06%) | 2(4.87%) | 1(20%) | 22(91.7%) | 24(88.88%) | 4(100%) |
| GMT | 0.31 | 2.14 | 1.09 | 122.4 | 130.98 | 306.76 |
GMT, geometric mean Titer.
Values in bold represent total number of infants in the corresponding categories.